Similarly, Montefusco et al. described persistent hyperglycemia and altered insulin secretion dynamics during convalescence, suggesting that the virus may act both as a trigger and as an accelerator of metabolic dysfunction [29]. This evidence concerns the gene INS and Hyperglycemia.